Literature DB >> 21290220

Animal models in overactive bladder research.

Brian A Parsons1, Marcus J Drake.   

Abstract

Overactive bladder syndrome (OAB) is a symptom-based diagnosis characterised by the presence of urinary urgency. It is highly prevalent and overlaps with the presence of bladder contractions during urine storage, which characterises the urodynamic diagnosis of detrusor overactivity. Animal models are needed to understand the pathophysiology of OAB, but the subjective nature of the symptom complex means that interpretation of the findings in animals requires caution. Because urinary urgency cannot be ascertained in animals, surrogate markers such as frequency, altered toileting areas, and non-micturition contractions have to be used instead. No model can recapitulate the subjective, objective, and related factors seen in the clinical setting. Models used include partial bladder outlet obstruction, the spontaneous hypertensive rat, the hyperlipidaemic rat, various neurological insults and some gene knock-outs. Strengths and weaknesses of these models are discussed in the context of the inherent difficulties of extrapolating subjective symptoms in animals.

Entities:  

Mesh:

Year:  2011        PMID: 21290220     DOI: 10.1007/978-3-642-16499-6_2

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  30 in total

1.  Impact of partial urethral obstruction on bladder function: time-dependent changes and functional correlates of altered expression of Ca²⁺ signaling regulators.

Authors:  David Burmeister; Tamer AbouShwareb; Ralph D'Agostino; Karl-Erik Andersson; George J Christ
Journal:  Am J Physiol Renal Physiol       Date:  2012-03-21

2.  Constitutively active phosphodiesterase activity regulates urinary bladder smooth muscle function: critical role of KCa1.1 channel.

Authors:  Wenkuan Xin; Qiuping Cheng; Rupal P Soder; Eric S Rovner; Georgi V Petkov
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-15

Review 3.  Does central sensitization help explain idiopathic overactive bladder?

Authors:  W Stuart Reynolds; Roger Dmochowski; Alan Wein; Stephen Bruehl
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

Review 4.  TRP channels in lower urinary tract dysfunction.

Authors:  J Franken; P Uvin; D De Ridder; T Voets
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

5.  A functional analysis of the influence of β3-adrenoceptors on the rat micturition cycle.

Authors:  Prajni Sadananda; Marcus J Drake; Julian F R Paton; Anthony E Pickering
Journal:  J Pharmacol Exp Ther       Date:  2013-09-05       Impact factor: 4.030

6.  BDNF overexpression in the bladder induces neuronal changes to mediate bladder overactivity.

Authors:  Mahendra P Kashyap; Subrata K Pore; William C de Groat; Christopher J Chermansky; Naoki Yoshimura; Pradeep Tyagi
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-01

7.  Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.

Authors:  Francis M Hughes; Nivardo P Vivar; James G Kennis; Jeffery D Pratt-Thomas; Danielle W Lowe; Brooke E Shaner; Paul J Nietert; Laura S Spruill; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

8.  Intravesical TRPV4 blockade reduces repeated variate stress-induced bladder dysfunction by increasing bladder capacity and decreasing voiding frequency in male rats.

Authors:  Liana Merrill; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-25       Impact factor: 3.619

9.  Social stress induces changes in urinary bladder function, bladder NGF content, and generalized bladder inflammation in mice.

Authors:  Gerald C Mingin; Abbey Peterson; Cuixia Shi Erickson; Mark T Nelson; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-08-06       Impact factor: 3.619

Review 10.  Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review.

Authors:  Emilio Sacco; Riccardo Bientinesi; Pierfrancesco Bassi; Diego Currò
Journal:  Int Urogynecol J       Date:  2016-02-17       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.